Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
10.64Price to Sales
VS
Market
Sector
Industry
History
$ 10.8Close
$ 6.56 - $ 12.79 52-Week Range
Ticker Information
Ticker
ZVRACompany Name
ZEVRA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQZEVRA THERAPEUTICS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ZVRA - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 660.15M | 10.64 | $ 62.02M |
| 3/31/2025 | $ 430.33M | 10.6 | $ 40.59M |
| 12/31/2024 | $ 428.6M | 18.15 | $ 23.61M |
| 9/30/2024 | $ 462.24M | 18.65 | $ 24.79M |
| 6/30/2024 | $ 367.8M | 15.33 | $ 23.99M |
| 3/31/2024 | $ 210.52M | 7.52 | $ 28.01M |
| 12/31/2023 | $ 224.08M | 8.16 | $ 27.46M |
| 9/30/2023 | $ 159.36M | 9.62 | $ 16.56M |
| 6/30/2023 | $ 183.24M | 11.08 | $ 16.54M |
| 3/31/2023 | $ 147.72M | 15.76 | $ 9.37M |
Key Performance Insights, Last 5 Years
- ZEVRA THERAPEUTICS INC's latest trailing twelve months (TTM) P/S stands at 3.36.
- Over the past 5 years, ZEVRA THERAPEUTICS INC's average P/S has been 12.32.
- The median P/S for ZEVRA THERAPEUTICS INC during this period was 11.2
- ZEVRA THERAPEUTICS INC reached its highest P/S over the past 5 years at 21.48.
- The lowest P/S recorded by ZEVRA THERAPEUTICS INC in the same timeframe 3.36
ZEVRA THERAPEUTICS INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for ZEVRA THERAPEUTICS INC is calculated as follows: Market Cap [ $ 41.35M ] / Revenues [ $ 12.3M ]
(=) P/S [ 3.36 ] ZVRA - Price to Sales, Last 5 years
3.36
Minimum
Sep 30, 2020
21.48
Maximum
Jun 30, 2022
12.32
Average
11.2
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |